1-1 of 1
The Intergroupe Français des Leucémies Myéloïdes Chronique (FIφLMC)
Close
Sort by
Journal Articles

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Clinical Trials & Observations Brief Report
Philippe Rousselot, Francoise Huguet, Delphine Rea, Laurence Legros, Jean Michel Cayuela, Odile Maarek, Odile Blanchet, Gerald Marit, Eliane Gluckman, Josy Reiffers, Martine Gardembas, François-Xavier Mahon, The Intergroupe Français des Leucémies Myéloïdes Chronique (FIφLMC)
Journal: Blood
Blood (2006) 109 (1): 58–60.
https://doi.org/10.1182/blood-2006-03-011239
Published: 2006